Engaged Capital Reaches Agreement with Nevro Corp. for Board Representation
Olshan represented Engaged Capital in its agreement with Nevro Corp. pursuant to which Kirt Karros was appointed to Nevro’s board and one incumbent director will depart the board. As part of the agreement, Mr. Karros was appointed to the Audit Committee and the company agreed to amend such committee’s charter to expressly provide it with the authority to make recommendations to the board regarding significant capital allocation decisions and the company’s capital allocation policy. Vice Chair of Olshan’s Shareholder Activism Practice Group Ryan Nebel, Ian Engoron and Joseph Ferrone represented Engaged Capital in connection with its investment in Nevro.